| 9.8 0.16 (1.66%) | 07-30 12:18 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.26 | 1-year : | 13.06 |
| Resists | First : | 10.5 | Second : | 11.18 |
| Pivot price | 10.17  |
|||
| Supports | First : | 9.39 | Second : | 7.81 |
| MAs | MA(5) : | 9.76 |
MA(20) : | 10.34 |
| MA(100) : | 11.02 |
MA(250) : | 11.73 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 19.9 |
D(3) : | 21 |
| RSI | RSI(14): 39.3 |
|||
| 52-week | High : | 15.1 | Low : | 9.22 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MED ] has closed above bottom band by 31.9%. Bollinger Bands are 15.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.79 - 9.86 | 9.86 - 9.91 |
| Low: | 9.39 - 9.46 | 9.46 - 9.51 |
| Close: | 9.55 - 9.65 | 9.65 - 9.74 |
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
Wed, 29 Jul 2026
BlackRock discloses 2.9% Medifast (NYSE: MED) ownership stake - Stock Titan
Wed, 29 Jul 2026
Medifast Stock to Post Q2 Earnings: What Investors Should Know - TradingView
Wed, 29 Jul 2026
Medifast Inc (MED) Q1 2024 Earnings Report - Results, Call & Slides - tipranks.com
Tue, 28 Jul 2026
Medifast Inc (MED) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tue, 28 Jul 2026
MED|Medifast Inc|Price:9.780|Chg%:-0.130 - TradingKey
Tue, 28 Jul 2026
Medifast Inc (MED) Q4 2025 Earnings Report - Results, Call & Slides - tipranks.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Industrials
|
|
|
Industry:
Specialty Business Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 4.1 (%) |
| Held by Institutions | 85.3 (%) |
| Shares Short | 1,640 (K) |
| Shares Short P.Month | 2,160 (K) |
| EPS | -1.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -5.8 % |
| Operating Margin | -7.2 % |
| Return on Assets (ttm) | -4.4 % |
| Return on Equity (ttm) | -9.9 % |
| Qtrly Rev. Growth | -34.3 % |
| Gross Profit (p.s.) | 21.82 |
| Sales Per Share | 31.12 |
| EBITDA (p.s.) | -0.36 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 4 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | -5.41 |
| PEG Ratio | 0.9 |
| Price to Book value | 0 |
| Price to Sales | 0.31 |
| Price to Cash Flow | 0 |
| Dividend | 1.64 |
| Forward Dividend | 0 |
| Dividend Yield | 16.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|